We are prioritizing non-dilutive and lower cost sources of capital. including potential government funding programs to support these efforts we have engaged a tier one group of advisors and are actively evaluating the most efficient funding pathways available to us we and our advisors are spending quality time in dc and we are pursuing multiple funding opportunities across various federal agencies these activities have included in-person meetings submitting certain proposals and or applications and establishing data rooms for diligence.

May 13, 2026 / receipt, needs a key / Steve Cates, CFO | earnings call 2026-05-13 | transcript f0012f25-657c-4a4f-aa07-5991c0d79159 | chars 7792-8334 | segment 7

Our R&D team is focused on developing a natural graphite-based anode material, including work aimed at developing lower swelling material that could potentially address opportunities in the energy sto

company_statement / Aug 13, 2026 / receipt, needs a key

I don't want to get into the specific programs, mainly because a lot of them are kind of competitive, right? And so we want to reserve that and not maybe give a roadmap to others that are seeking fund

company_statement / Aug 13, 2026 / receipt, needs a key

We are focused on non-dilutive and lower cost capital where available. We are making decisions with long-term shareholder value in mind. The XM approval reflects that approach. It is not the end of th

company_statement / Aug 13, 2026 / receipt, needs a key

General and administrative expenses increased primarily due to higher stock-based compensation, increased third-party services related to the evaluation of government funding opportunities, and other

company_statement / Aug 13, 2026 / receipt, needs a key

We continue to expect Phase 1 development capital of $245 million, of which $115 million has not yet been incurred. That amount includes approximately $15 million in contingency. We have and are curre

company_statement / Aug 13, 2026 / receipt, needs a key